Shiraz E-Medical Journal

Published by: Kowsar

Impact of HBV Vaccination on Prevalence of Hepatitis B Virus Infection Among Volunteer Blood Donors in Tehran-Iran

Seyed Mohammad Mirrezaie 1 , 2 , Hamid Reza Saber 1 , 2 , Bashir Hajibeigi 1 , 2 , Ebadollah Salekmoghaddam 1 , 2 , Ali Abbasian 1 , 2 and Seyed Moayed Alavian 3 , 4 , *
Authors Information
1 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IR Iran
2 Tehran Regional Educational Blood Transfusion Center, Tehran, IR Iran
3 Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
4 Middle East Liver Disease Center, Tehran, IR Iran
Article information
  • Shiraz E-Medical Journal: April 01, 2014, 15 (2); e18066
  • Published Online: April 20, 2014
  • Article Type: Research Article
  • Received: February 6, 2014
  • Accepted: March 13, 2014
  • DOI: 10.17795/semj18066

To Cite: Mirrezaie S M, Saber H R, Hajibeigi B, Salekmoghaddam E, Abbasian A, et al. Impact of HBV Vaccination on Prevalence of Hepatitis B Virus Infection Among Volunteer Blood Donors in Tehran-Iran, Shiraz E-Med J. 2014 ; 15(2):e18066. doi: 10.17795/semj18066.

Copyright © 2014, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Alavian SM, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, et al. Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study. Int J Prev Med. 2012; 3(11): 770-5[PubMed]
  • 2. Alavian SM, Lankarani KB. Hepatitis B Virus Infection; A Vanishing Disease in Iranian Children. J Compr Ped. 2012; 3(1): 1-2
  • 3. Alavian SM. Ministry of Health in Iran is serious about controlling hepatitis B. Hepat Mon. 2007; 7(1): 3-5
  • 4. de Paula Machado DF, Martins T, Trevisol DJ, Vieira ESRA, Narciso-Schiavon JL, Schuelter Trevisol F, et al. Prevalence and factors associated with hepatitis B virus infection among senior citizens in a southern brazilian city. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 5. Adibi P. Why we still need HBV population-based epidemiologic studies. Hepat Mon. 2012; 12(2): 71-2[DOI][PubMed]
  • 6. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002; 2(7): 395-403[PubMed]
  • 7. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 8. Salehi M, Alavian SM, Tabatabaei SV, Izadi S, Sanei Moghaddam E, Amini Kafi-Abad S, et al. Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J. 2012; 14(5): 283-8[PubMed]
  • 9. Alavian SM, Tabatabaei SV, Nourizad S, Mansouri F, Khademi N, Kafi-abad SA, et al. Seroepidemiology of HBV Infection in Kermanshah-West of Iran; A Population Based Study. Jundishapur JMicrobiol. 2012; 5(4)
  • 10. Campagna M, Siddu A, Meloni A, Basciu C, Ferrai L, Pettinau A, et al. Changing pattern of hepatitis a virus epidemiology in an area of high endemicity. Hepat Mon. 2012; 12(6): 382-5[DOI][PubMed]
  • 11. Van Herck K, Van Damme P. Benefits of early hepatitis B immunization programs for newborns and infants. Pediatr Infect Dis J. 2008; 27(10): 861-9[DOI][PubMed]
  • 12. Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2005; 11(1-2): 62-7[PubMed]
  • 13. Kabir A, Alavian SM, Ahanchi N, Malekzadeh R. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatol Res. 2006; 36(4): 265-71[DOI][PubMed]
  • 14. Alam Mehrjerdi Z, Noroozi A. An emerging trend of methamphetamine injection in iran: a critical target for research on blood-borne infection diseases. Hepat Mon. 2013; 13(2)[DOI][PubMed]
  • 15. Nokhodian Z, Yazdani MR, Yaran M, Shoaei P, Mirian M, Ataei B, et al. Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran. Hepat Mon. 2012; 12(7): 442-7[DOI][PubMed]
  • 16. Alavian SM, Gooya MM, Hajarizadeh B, Esteghamati AR, Moeinzadeh AM, Haghazali M, et al. Mass Vaccination Campaign against Hepatitis B in Adolescents in Iran: Estimating Coverage Using Administrative Data. Hepat Mon. 2009; 9(3)
  • 17. Yoshikawa A, Suzuki K, Abe A, Tanaka T, Yamaguchi K, Tanaka T, et al. Effect of selective vaccination on a decrease in the rate of hepatitis B virus-positive Japanese first-time blood donors. Transfus Med. 2009; 19(4): 172-9[DOI][PubMed]
  • 18. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon. 2008; 8(4)
  • 19. Mackie CO, Buxton JA, Tadwalkar S, Patrick DM. Hepatitis B immunization strategies: timing is everything. CMAJ. 2009; 180(2): 196-202[DOI][PubMed]
  • 20. Sakarya S, Oncu S, Ozturk B, Oncu S. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey. Saudi Med J. 2004; 25(8): 1070-2[PubMed]
  • 21. Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010; 202(2): 192-201[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments